Pradžia › Ūmi limfoblastinė leukemija › Ohio › Cincinnati
Ūmi limfoblastinė leukemija klinikiniai tyrimai Cincinnati, OH
12 tyrimai dėl Ūmi limfoblastinė leukemija ieško dalyvių vietose Cincinnati ir aplinkui (apytiksliai 30 mylių spinduliu). Atidarykite tyrimą, kad pamatytumėte, kas gali dalyvauti ir kaip susisiekti su tyrimo komanda.
Oficialus tyrimo tekstas (anglų kalba)
Ieškote dalyvių tyrimui? Pateikite jį šio puslapio viršuje – $99 už 30 dienų →
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Renkami dalyviaiStebimasis tyrimasLaukiami sveiki savanoriai
- Good Samaritan Hospital - Cincinnati, Cincinnati
- Oncology Hematology Care Inc-Kenwood, Cincinnati
- Bethesda North Hospital, Cincinnati
- ir dar 3
Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
Renkami dalyviaiStebimasis tyrimas
- Cincinnati Children's Hospital Medical Center, Cincinnati
A Phase 2 Study of WU-CART-007, an Anti-CD7 Allogeneic CAR-T Cell Therapy in T-Cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma (T-RRex)
Renkami dalyviai2 fazė
- Oncology Hematology Care, Cincinnati
- Cincinnati Children's Hospital Medical Center, Cincinnati
First-in-human Study of a New Treatment (4A10) for Patients With Relapsed or Hard-to-treat Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma, Focused on Safety and How the Drug Behaves in the Body and Early Signs of Effect.
Renkami dalyviai1 fazė
- Cincinnati Children's Hospital Medical Center, Cincinnati
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
Renkami dalyviai1/2 fazė
- Cincinnati Children's Hospital Medical Center, Cincinnati
Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL
Renkami dalyviai2 fazė
- Cincinnati Children's Hospital Medical Center, Cincinnati
Safety Study to Evaluate the Occurrence of EFAD in Pediatric Patients With PNAC Who Require More Than Eight Weeks of Omegaven Treatment
Renkami dalyviaiStebimasis tyrimas
- Children's Hospital Medical Center, Cincinnati
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
Renkami dalyviaiStebimasis tyrimas
- Cincinnati Children's Hospital, Cincinnati
Study of CM4620 to Reduce the Severity of Pancreatitis Due to Asparaginase
Renkami dalyviai1/2 fazė
- Cincinnati Children's Hospital Medical Center, Cincinnati
Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
Renkami dalyviaiStebimasis tyrimas
- Cincinnati Children's Hospital Medical Center, Cincinnati
Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL.
Renkami dalyviai1 fazė
- Cincinnati Children's Hospital Medical Center, Cincinnati
- University of Cincinnati, Cincinnati
Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies
Renkami dalyviai1 fazė
- Cincinnati Children's Hospital Medical Center, Cincinnati
Ūmi limfoblastinė leukemija tyrimai kituose miestuose
- Houston, TX28 tyrimai
- New York City, NY24 tyrimai
- Baldwin Park, CA21 tyrimas
- Seattle, WA21 tyrimas
- Chicago, IL19 tyrimai
- Atlanta, GA19 tyrimai
- Philadelphia, PA16 tyrimai
- Memphis, TN16 tyrimai
- Washington, DC16 tyrimai
- Boston, MA15 tyrimai
- Los Angeles, CA14 tyrimai
- Durham, NC13 tyrimai
Kiti tyrimai Cincinnati
- Nedidelinių ląstelių plaučių vėžys35 tyrimai
- Vėžys (visų tipų)27 tyrimai
- Krūties vėžys25 tyrimai
- Širdies nepakankamumas24 tyrimai
- Storosios ir tiesiosios žarnos vėžys21 tyrimas
- Ūmi mieloidinė leukemija20 tyrimai
- Metastatinis vėžys20 tyrimai
- Kiaušidžių vėžys19 tyrimai
- Plaučių vėžys19 tyrimai
- Nutukimas19 tyrimai
- Prostatos vėžys18 tyrimai
- Kartotinė mieloma17 tyrimai
Iš ClinicalTrials.gov, duomenys gauti 2026-10-05. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.